Presentation TCT 2018 Case #3: A Case of Bioprosthetic Valve Fracture To Facilitate TAVR ViV Presenter: Massimo Napodano, Bernard Prendergast, Mohamed Abdel-Wahab, Robert J. Applegate, Vinayak Bapat, Alaide Chieffo, Jan Kovac, Juan A. Terré September 22, 2018
Presentation TCT 2018 Case #2: A Case of TAVR in TAVR Presenter: Massimo Napodano, Bernard Prendergast, Mohamed Abdel-Wahab, Robert J. Applegate, Vinayak Bapat, Alaide Chieffo, Jan Kovac, Juan A. Terré September 22, 2018
Presentation TCT 2018 Case #1: A Case of TAVR ViV Requiring an Advanced Approach Presenter: Massimo Napodano, Bernard Prendergast, Mohamed Abdel-Wahab, Robert J. Applegate, Vinayak Bapat, Alaide Chieffo, Jan Kovac, Juan A. Terré September 22, 2018
Presentation TCT 2018 Introduction: What Do We Hope to Learn From These Cases? Presenter: Massimo Napodano, Bernard Prendergast September 22, 2018
Presentation TCT 2018 Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends Presenter: Michael J. Mack, Bernard Prendergast, George D. Dangas September 22, 2018
Presentation TCT 2018 New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability Presenter: Michael J. Mack, Bernard Prendergast, Davide Capodanno September 22, 2018
Presentation TCT 2018 Aortic Arch Neuromodulation for Chronic Heart Failure: EnoPace Presenter: James E. Udelson, Clyde W. Yancy, Felix Mahfoud September 22, 2018
Presentation TCT 2018 The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies Presenter: Michael J. Mack, Bernard Prendergast, Lars Sondergaard September 22, 2018
Presentation TCT 2018 To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures Presenter: Michael J. Mack, Bernard Prendergast, Adam B. Greenbaum September 22, 2018
Presentation TCT 2018 To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures Presenter: Michael J. Mack, Bernard Prendergast, Adnan K. Chhatriwalla September 22, 2018
Presentation TCT 2018 How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures Presenter: Michael J. Mack, Bernard Prendergast, Philipp Blanke September 22, 2018
Presentation TCT 2018 Clinical Lessons from the Global Aortic VIVID Registry Optimizing Procedural Outcomes Presenter: Michael J. Mack, Bernard Prendergast, John G. Webb September 22, 2018
Presentation TCT 2018 Status Update of the TAVR UNLOAD Trial Moderate AS Patients with Reduced Ejection Fraction and Heart Failure Presenter: Allan Schwartz, Stephan Windecker, Joost Daemen September 22, 2018
Presentation TCT 2018 Putting It All Together: A Proposed New Staging Classification for Patients with Aortic Stenosis Presenter: Philippe Genereux September 22, 2018
Presentation TCT 2018 Who Should be Treated? The Role of Biomarkers in Patient Selection and Procedure Optimization Presenter: Eric Van Belle September 22, 2018
Presentation TCT 2018 Who Should be Treated? The Role of Imaging Guidance in Patient Selection Presenter: Philippe Pibarot September 22, 2018
Presentation TCT 2018 Rationale for Treating SASS and Update of the EARLY-TAVR Trial Presenter: Allan Schwartz September 22, 2018
Presentation TCT 2018 My Crystal Ball - Predicting the Role of Surgery and Surgeons in the Treatment of Aortic Stenosis Once the Cycle of Low-Risk Studies is Completed Presenter: Allan Schwartz, Stephan Windecker, Michael J. Reardon September 22, 2018
Presentation TCT 2018 The Case for TAVR in Low-Risk Patients: Rationale, Current Data, Clinical Trends, and Updates from the Ongoing Clinical Trials Presenter: Allan Schwartz, Stephan Windecker, Jeffrey J. Popma September 22, 2018
Presentation TCT 2018 TCT-7: Predictors and Outcomes of Aborted Procedures During Elective Transcatheter Aortic Valve Replacement Presenter: Steven R. Bailey, Patrick W. Serruys, Jennifer Rymer September 22, 2018